Research
Hormonal
Tirzepatide had superiority over placebo or other antidiabetic agents in controlling lipid and waist circumference levels.
Tirzepatide may be a preferred treatment option for improving lipid profiles and waist circumference in patients with type 2 diabetes.
StrongSupportsmedium confidence
Tirzepatide had superiority over placebo or other antidiabetic agents in controlling lipid and WC levels.
Why this rating
The claim is based on a systematic review and meta-analysis of randomized controlled trials.
Source
Effect of the Dual Glucose‐Dependent Insulinotropic Peptide/Gulcagon‐like Peptide 1 Receptor Agonist Tirzepatide on Lipid Profile and Waist Circumference: A Systematic Review and Meta‐analysis
Dan Yu et al. · Clinical Therapeutics · 2023
Meta-analysisCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →